Surgery Partners Q2 revenue +14.2% to $762.1M; raises FY2024 guidance

Surgery Partners, Inc.

2024-Q2 EPS reported -$0.22 revenue$1,479,500,000

Revenue $762.1M (+14.2% YoY); same-facility revenue up 9.9%, cases up 3.9%.
Adjusted EBITDA $118.3M (+18.1%); margin 15.5% (+50 bps).
Net loss attributable to company $15.5M.
FY2024 guidance raised: revenue >$3.075B, Adjusted EBITDA >$508M.
Deployed ~$220M on acquisitions YTD; balance sheet refinanced and hedged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.